Department of Health
The 2024 Post-Acute Sequelae of COVID-19 (PASC) grant opportunity will provide up to $28 million for medical research and innovation projects that:
- support the development of novel diagnostic or monitoring tools, or therapies for people living with PASC
- improve the quality of care for people who have symptoms or are living with PASC.
PASC is also known as long COVID.
This is the second grant opportunity under the $50 million MRFF PASC Research Plan. Funding is from the MRFF's Emerging Priorities and Consumer-Driven Research initiative.
/Media Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
